Royal Bank of Canada
CRGX

Royal Bank of Canada’s CARGO Therapeutics CRGX Stock Holding History

Royal Bank of Canada’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,221
Closed -$13K – 7187
2025
Q2 		$13K Buy
3,221
+1,382
+75% +$5.92K ﹤0.01% 6400
2025
Q1 		$7K Sell
1,839
-2,457
-57% -$16.5K ﹤0.01% 6251
2024
Q4 		$62K Buy
4,296
+326
+8% +$5.92K ﹤0.01% 5580
2024
Q3 		$73K Buy
3,970
+2,123
+115% +$38K ﹤0.01% 5519
2024
Q2 		$30K Buy
1,847
+1,365
+283% +$26K ﹤0.01% 5885
2024
Q1 		$11K Buy
482
+472
+4,720% +$11.2K ﹤0.01% 6156
2023
Q4 		$0 Buy
+10
New +$170 ﹤0.01% 7184

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's CRGX Position: Q3 2025 in Review

Royal Bank of Canada sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 3,221 shares — an estimated $13K sold.

Royal Bank of Canada first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $73K in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Royal Bank of Canada reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 3,221 CARGO Therapeutics shares in Q3 2025, an estimated $13K.
  • Royal Bank of Canada first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
  • Royal Bank of Canada's CARGO Therapeutics position peaked at $73K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.